You are now viewing 1 - 10 of 16 results
October 1, 2012 | Journal Article
This study examines how different drug plan benefit and formulary designs influence the selection of generic drugs to treat high cholesterol among Medicare beneficiaries.
May 1, 2012 | Journal Article
Value-based insurance design bases cost sharing on a medication's clinical value, not its price. This study shows the effectiveness of value-based insurance design.
November 1, 2010 | Journal Article
A large value-based insurance design program offered by Blue Cross Blue Shield of North Carolina eliminated generic medication copayments and reduced copayments for brand-name medications.
January 1, 1997 | Program Result Report
From 1992 to 1995, researchers at Harvard Medical School collected a comprehensive cross-section of data on state Medicaid pharmaceutical programs and various models of cost-containment. They also investigated the impacts of five cost-containment methods.
March 6, 2008 | Program Result Report
Researchers at Brandeis University used data from two state-run prescription drug programs for low-income seniors to examine how differences in prescription drug coverage affect enrollment, drug use and spending in state programs.
July 31, 2008 | Program Result Report
Pharmacogenomics is the study of how inherited variations in genes dictate a person's reaction to a drug. Louis F. Rossiter, PhD, and other researchers examined how pharmacogenomics fits within the current health care market.
April 19, 2012 | Journal Article
New report examines the impact of the Medicare Modernization Act on access to cancer chemotherapy treatment.
April 1, 2012 | Issue Brief
Spending on specialty drugs—typically high-cost biologics used to treat a variety of serious, complex conditions ranging from blood disorders to rheumatoid arthritis—has been growing at a persistently high rate in recent years.
October 11, 2011 | Video
This short infographic video explains what the Medicare Part D donut hole is and how it changes under health reform.
August 1, 2011 | Journal Article
Higher medication adherence rates for two classes of drugs saved Medicare dollars over three years.